Stockscreener 앱 받기
11.57
0.09%
0.010
시간 외 거래:
11.57
전일 마감가:
$11.56
열려 있는:
$11.6343
하루 거래량:
2,333
Relative Volume:
0.45
시가총액:
$32.96M
수익:
-
순이익/손실:
$65,400
주가수익비율:
-771.33
EPS:
-0.015
순현금흐름:
$-1.12M
1주 성능:
-0.60%
1개월 성능:
-1.11%
6개월 성능:
+3.95%
1년 성능:
+6.15%
1일 변동 폭
$11.57
$11.68
1주일 범위
$11.56
$11.68
52주 변동 폭
$10.89
$12.74
Bannix Acquisition Corp Stock (BNIX) Company Profile
명칭
Bannix Acquisition Corp
전화
(201) 712-9800
주소
300 TICE BLVD, WOODCLIFF LAKE
BNIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNIX
Bannix Acquisition Corp
|
11.57 | 32.96M | 0 | 65,400 | -1.12M | -0.015 |
|
LION
Lionsgate Studios Corp
|
8.31 | 2.40B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.06 | 691.25M | 0 | 16.92M | -1.35M | 0.29 |
|
GCL
Gcl Global Holdings Ltd
|
3.77 | 475.87M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.55 | 454.97M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.17 | 447.22M | 0 | 0 | 0 | 0.00 |
Bannix Acquisition Corp 주식(BNIX)의 최신 뉴스
How to Take Advantage of moves in (BNIX) - Stock Traders Daily
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - Marketscreener.com
Bannix Acquisition announces monthly extension to complete business combination - TipRanks
Bannix Acquisition Corp. Extends Business Combination Deadline - TipRanks
Bannix and VisionWave Announce filing of a registration statement on Form S-4 - The Manila Times
Defense Tech Giant VisionWave Takes Major Step Toward $1B Public Market Debut - StockTitan
(BNIX) Technical Data - Stock Traders Daily
BNIX stock soars to all-time high of $11.8 amid robust growth - MSN
Bannix Acquisition Corp defers $2.95M in costs - Investing.com India
Bannix Acquisition Corp defers $2.95M in costs By Investing.com - Investing.com Australia
CNH announces Global Leadership Team changes - The Manila Times
Bannix Acquisition Corp. Extends Initial Business Combination Deadline to January 14, 2025 - Nasdaq
Bannix Acquisition Corp Extends SPAC Deadline Again in Search for Merger Target - StockTitan
Bannix Acquisition Corp. faces Nasdaq delisting notice - Investing.com India
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors - The Manila Times
Bannix Acquisition Corp. Extends Deadline for Business Merger - TipRanks
BNIXBannix Acquisition Corp. Latest Stock News & Market Updates - StockTitan
Bannix Acquisition Corp. Extends Business Combination Deadline to December 2024 | BNIX Stock News - StockTitan
Bannix Acquisition Corp. (BNIX) Quarterly 10-Q Report - Quartzy
Long Term Trading Analysis for (BNIX) - Stock Traders Daily
How to Trade US Stocks in Singapore Right Now - Benzinga
(BNIX) Trading Advice - Stock Traders Daily
Arcology introduces Ethereum's first parallel execution rollup - The Manila Times
Bannix Acquisition Corp. Extends Merger Deadline to 2024 - TipRanks
(BNIX) Investment Report - Stock Traders Daily
BP share price weakness is presenting a golden opportunity for long-term investors - Yahoo Finance UK
(BNIX) Trading Signals - Stock Traders Daily
Canopy Growth Announces Results of Annual General Meeting - Yahoo Canada Finance
How Many Stocks Are There in 2024? - Benzinga
James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
BANX stock touches 52-week high at $20.8 amid robust growth - Investing.com Canada
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Positive Ascendis data threatens BioMarin's lead in achondroplasia - The Pharma Letter
Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World
Ascendis Challenges BioMarin, But Market Response Seems Excessive (NASDAQ:BMRN) - Seeking Alpha
Ascendis trial data piles pressure on BioMarin - BioPharma Dive
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology
Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter
BANPU Surges 6% Following NatGas Unit Launching IPO in NYSE - KAOHOON INTERNATIONAL
Bannix Acquisition Corp. Strives to Secure VisionWave Merger - TipRanks
U.S. Markets Finished Mixed Monday As Carvana Led, BioMarin Pharmaceutical Lagged - Barron's
Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term - Yahoo Finance
BioMarin off 17% as Ascendis data seen as threat to Voxzogo - Seeking Alpha
Ascendis rises on positive trial data for dwarfism therapy - XM
Banzai International Inc’s latest rating changes from various analysts - Knox Daily
(BNIX) On The My Stocks Page - Stock Traders Daily
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada
Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
Bannix Acquisition Corp (BNIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.10%
자본화:
|
볼륨(24시간):